WSJ News Exclusive | AbbVie Aims for New Drugs to Boost Sales as Competitors Target Humira

pharmaceutical company ABV Inc. is looking for its next hit. Now its blockbuster immune-disease therapy Humira…

Merck Strikes $1.35 Billion Deal for Bone-Marrow Disease Drug Developer

Health Merck agrees to pay $36 a share cash for Imago BioSciences

WSJ News Exclusive | Merck in advanced talks to buy Seagen for roughly $40 billion or more

Merck & Co in advanced talks for acquisition season and aiming to agree to a purchase…

Biotech wizard left a trail of fraud – prosecutors allege it ended in murder

Serhat Gumrukku faces trial in an alleged murder-for-hire plot to silence an aide who could have…

Biotech wizard left a trail of fraud – prosecutors allege it ended in murder

Serhat Gumrukku faces trial in an alleged murder-for-hire plot to silence an aide who could have…

AstraZeneca breast-cancer drug shows slow tumor progression

a new study astraZeneca PLC breast-cancer drug showed that it halved the risk of tumor progression…